Document Detail

Effects of aspirin and desmopressin on platelet reactivity in patients undergoing cardiac surgery with extracorporeal circulation.
MedLine Citation:
PMID:  21057697     Owner:  NLM     Status:  MEDLINE    
The effect of desmopressin on platelet function in patients with continued antiplatelet therapy undergoing cardiac surgery is discussed controversially. We assessed platelet reactivity in 86 patients undergoing elective coronary artery bypass grafting (CABG) under extracorporeal circulation. Twenty-nine of these patients were without preoperative antiplatelet therapy (group A), while 57 were treated with acetylsalicylic acid (ASA) 100 mg qd up to the day of surgery. Out of this cohort, 24 patients received no desmopressin perioperatively (group B), whereas 33 patients were treated with desmopressin 0.4 microg/kg after administration of protamine due to increased bleeding tendency (group C). Multiple electrode platelet aggregometry with arachidonic acid as agonist showed a marked decrease of platelet reactivity in patients without antiplatelet therapy immediately after extracorporeal circulation compared to preoperative control (375 ± 227 vs. 749 ± 330 AU*min, p<0.001). Platelet reactivity recovered to preoperative controls in group A at 24 hours after protamine administration (662 ± 295 AU*min). Platelet reactivity in patients on ASA was not decreased further after extracorporeal circulation (group B: 197 ± 126 vs. 251 ± 203 AU*min, p=0.14; group C: 212 ± 100 vs. 245 ± 248 AU*min, p=0.43) and improved significantly within 24 hours. A statistically significant effect of desmopressin, however, could not be determined (group B: 392 ± 223 AU*min; group C: 439 ± 324 AU*min at 24 hours after protamine, p=0.63 for between-subjects contrast). Our data suggest that desmopressin does not affect platelet reactivity in patients on ASA undergoing CABG and is, therefore, not useful in this clinical setting.
Cornelius Keyl; Eliane Kmitta; Ssmi Kueri; Tomasz Zietak; Dietmar Trenk
Related Documents :
10551997 - Inhibition of platelet aggregation by the gpiib/iiia antagonist reopro does not signifi...
20624007 - The nitrative and oxidative stress in blood platelets isolated from breast cancer patie...
12624817 - Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats.
24677617 - Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement:...
24429827 - Sgk1 sensitive pendrin expression in murine platelets.
8485117 - Plasminogen activator inhibitor-1 mrna is expressed in platelets and megakaryocytes and...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article     Date:  2010-11-05
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  105     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-04     Completed Date:  2011-05-18     Revised Date:  2011-05-23    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  113-21     Citation Subset:  IM    
Department of Anaesthesiology, Heart Centre Bad Krozingen, Bad Krozingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspirin / administration & dosage,  pharmacology*
Blood Platelets / drug effects
Cardiac Surgical Procedures / methods*
Coronary Artery Bypass / methods*
Deamino Arginine Vasopressin / administration & dosage,  pharmacology*
Middle Aged
Platelet Activation / drug effects*
Platelet Aggregation Inhibitors
Protamines / administration & dosage
Reg. No./Substance:
0/Hemostatics; 0/Platelet Aggregation Inhibitors; 0/Protamines; 16679-58-6/Deamino Arginine Vasopressin; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High incidence of ankle arthropathy in mild and moderate haemophilia A.
Next Document:  Role of intramural platelet thrombus in the pathogenesis of wall rupture and intra-ventricular throm...